IMMUNOVIA AB news, videos and press releases - Page 5
For more news please use our advanced search feature.
IMMUNOVIA AB - More news...
IMMUNOVIA AB - More news...
- Nomination Committee appointed for the 2023 Annual General Meeting of Immunovia AB (Publ)
- Nomination Committee appointed for the 2023 Annual General Meeting of Immunovia AB (Publ)
- Immunovia announces executive management team changes to accelerate execution of strategic priorities
- Immunovia launches a strategic partnership with Proteomedix to leverage R&D efforts with increased focus on commercialization
- Immunovia launches a strategic partnership with Proteomedix to leverage R&D efforts with increased focus on commercialization
- Immunovia announces positive update on physician experience program with IMMray™ PanCan-d
- Centers for Medicare & Medicaid Services issues preliminary payment rate determination for Immunovia's IMMray PanCan-d test
- Immunovia Publishes Interim Report Jan-June 2022
- Immunovia Publishes Interim Report Jan-June 2022
- Immunovia to present at Gilmartin Group's Emerging Growth Company Showcase
- Invitation to Immunovia's Q2 presentation
- Invitation to Immunovia's Q2 presentation
- Immunovia, Inc. Issued Clinical and Public Health Laboratory License from California Dept of Public Health for IMMray™ PanCan-d test
- Immunovia: CPT PLA Code for the IMMray™ PanCan-d test approved
- The PanDIA-1 study, for early detection of pancreatic cancer in newly onset type 2 diabetics, moves into next phase
- Invitation to Immunovia's Presentation of PanFAM-1 Results
- Invitation to Immunovia's Presentation of PanFAM-1 Results
- PanFAM-1 Results Partly Inconclusive
- PanFAM-1 Results Partly Inconclusive
- Philipp Mathieu appointed CEO of Immunovia AB
- Immunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Departments of Health making IMMray™ PanCan-d test available in 48 US states
- Immunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray™ PanCan-d test available in 46 US states
- Immunovia strengthens its US team through the appointment of Natalie Carfora as Head of Market Access US
- Immunovia Publishes Interim Report January-March 2022
- Immunovia Publishes Interim Report January-March 2022
- Invitation to Immunovia's Q1 presentation
- Invitation to Immunovia's Q1 presentation
- Immunovia CPT PLA Code submission for the IMMray™ PanCan-d test is on the agenda of American Medical Association
- Communiqué from the Annual General Meeting in Immunovia AB
- Communiqué from the Annual General Meeting in Immunovia AB
